Efficient priming of simian/human immunodeficiency virus (SHIV)-specific T-cell responses with DNA encoding hybrid SHIV/hepatitis B surface antigen particles

Vaccine

Volumn 22, Issue 27-28, 2004, Pages 3535-3545

  Puaux, Anne Laure ^a   Marsac, Delphine ^a,b   Prost, Stéphane ^c   Singh, Mandal K ^d,e   Earl, Patricia ^f   Moss, Bernard ^f   Le Grand, Roger ^c   Riviere, Yves ^d   Michel, Marie Louise ^a  

^a INSERM   (France)

^b UNIVERSITY OF CHILE   (Chile)

^c DSV/DRM   (France)

^d CNRS   (France)

^e ALLEGHENY SINGER RESEARCH INSTITUTE   (United States)

^f NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

DNA immunisation; HBsAg; Rhesus macaque; SHIV

Indexed keywords

DNA VACCINE; GAG PROTEIN; GAMMA INTERFERON; HEPATITIS B SURFACE ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; NEF PROTEIN; VIRUS DNA; VIRUS ENVELOPE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE CONSTRUCT; GENETIC CODE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; IMMUNOGENICITY; INTERFERON PRODUCTION; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE ACTIVATION; VIRUS HYBRID; VIRUS RECOMBINANT; VIRUS REPLICATION;

AIDS VACCINES; ANIMALS; AREA UNDER CURVE; CD4-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CYTOMEGALOVIRUS; DNA; DNA PROBES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENETIC VECTORS; HEPATITIS B SURFACE ANTIGENS; HIV; IMMUNIZATION, SECONDARY; INTERFERON TYPE II; KINETICS; MACACA MULATTA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SAIDS VACCINES; SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES; VACCINES, DNA; VACCINES, SUBUNIT; VACCINIA; VIRUS REPLICATION;

EID: 4143076986     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.03.044     Document Type: Article

References (52)

1. McMichael A.J., Hanke T. HIV vaccines 1983-2003. Nat Med. 9(7):2003;874-880
2. Koup R.A., Saffrit J.T., Cao Y., Andrews C.A., McLeod G., Borkowsky W., et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol. 68:1994;6103-6110
3. Kaul R., Dong T., Plummer F.A., Kimani J., Rostron T., Kiama P., et al. CD8(+) lymphocytes respond to different HIV epitopes in seronegative and infected subjects. J Clin Invest. 107(10):2001;1303-1310
4. Riviere Y., McChesney M.B., Porrot F., Tanneau-Salvadori F., Sansonetti P., Lopez O., et al. Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS-related complex or AIDS. AIDS Res Hum Retrovir. 11(8):1995;903-907
5. Chouquet C., Autran B., Gomard E., Bouley J.M., Calvez V., Katlama C., et al. Correlation between breadth of memory HIV-specific cytotoxic T-cells, viral load and disease progression in HIV infection. AIDS. 16(18):2002;2399-2407
6. Jin X., Bauer D.E., Tuttleton S.E., Lewin S., Gettie A., Blanchard J., et al. Dramatic rise in plasma viremia after CD8(+) T-cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med. 189(6):1999;991-998
7. Schmitz J.E., Kuroda M.J., Santra S., Sasseville V.G., Simon M.A., Lifton M.A., et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science. 283(5403):1999;857-860
8. Matano T., Shibata R., Siemon C., Connors M., Lane H.C., Martin M.A. Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques. J Virol. 72(1):1998;164-169
9. Rosenberg E.S., Billingsley J.M., Caliendo A.M., Boswell S.L., Sax P.E., Kalams S.A., et al. Vigorous HIV-1-specific CD4+ T-cell responses associated with control of viremia. Science. 278(5342):1997;1447-1450
10. Villinger F., Brice G.T., Mayne A.E., Bostik P., Mori K., June C.H., et al. Adoptive transfer of simian immunodeficiency virus (SIV) naive autologous CD4(+) cells to macaques chronically infected with SIV is sufficient to induce long-term nonprogressor status. Blood. 99(2):2002;590-599
11. Hel Z., Nacsa J., Tryniszewska E., Tsai W.P., Parks R.W., Montefiori D.C., et al. Containment of simian immunodeficiency virus infection in vaccinated macaques: correlation with the magnitude of virus-specific pre- and postchallenge CD4+ and CD8+ T-cell responses. J Immunol. 169(9):2002;4778-4787
12. Pitcher C.J., Quittner C., Peterson D.M., Connors M., Koup R.A., Maino V.C., et al. HIV-1-specific CD4+ T-cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression. Nat Med. 5(5):1999;518-525
13. McMichael A.J., Rowland-Jones S.L. Cellular immune responses to HIV. Nature. 410(6831):2001;980-987
14. Schirmbeck R., Melber K., Mertens T., Reimann J. Antibody and cytotoxic T-cell responses to soluble hepatitis B virus (HBV) S antigen in mice: implication for the pathogenesis of HBV-induced hepatitis. J Virol. 68(3):1994;1418-1425
15. Malanchere-Bres E., Payette P.J., Mancini M., Tiollais P., Davis H.L., Michel M.L. CpG oligodeoxynucleotides with hepatitis B surface antigen (HBsAg) for vaccination in HBsAg-transgenic mice. J Virol. 75(14):2001;6482-6491
16. Michel M.L., Mancini M., Sobczak E., Favier V., Guetard D., Bahraoui E.M., et al. Induction of anti-human immunodeficiency virus (HIV) neutralizing antibodies in rabbits immunized with recombinant HIV-hepatitis B surface antigen particles. Proc Natl Acad Sci U S A. 85(21):1988;7957-7961
17. Schlienger K., Mancini M., Rivière Y., Dormont D., Tiollais P., Michel M.-L. Human immunodeficiency virus type 1 major neutralizing determinant exposed on hepatitis B surface antigen particles is highly immunogenic in primates. J Virol. 66(4):1992;2570-2576
18. Schlienger K., Montefiori D.C., Mancini M., Rivière Y., Tiollais P., Michel M.-L. Vaccine-induced neutralizing antibodies directed in part to the simian immunodeficiency virus (SIV) V2 domain were unable to protect rhesus monkeys from SIV experimental challenge. J Virol. 68:1994;6578-6588
19. Lalvani A., Moris P., Voss G., Pathan A.A., Kester K.E., Brookes R., et al. Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S/SBAS2, a recombinant Plasmodium falciparum malaria vaccine. J Infect Dis. 180(5):1999;1656-1664
20. Mancini M., Schlienger K., Tiollais P., Michel M.L. Immunogenicity of hybrid hepatitis B surface antigen particles. Int Rev Immunol. 11(2):1994;143-151
21. Le Borgne S., Le Grand R., Michel M.L., Vaslin B., Boson B., Janvier G., et al. Immune responses following simian/human immunodeficiency virus (SHIV) challenge of rhesus macaques after human immunodeficiency virus (HIV)-1 third variable domain (V3) loop-based genetic immunization. J Med Primatol. 29(6):2000;371-386
22. Le Borgne S., Mancini M., Le Grand R., Schleef M., Dormont D., Tiollais P., et al. In vivo induction of specific cytotoxic T lymphocytes in mice and rhesus macaques immunized with DNA vector encoding an HIV epitope fused with hepatitis B surface antigen. Virology. 240(2):1998;304-315
23. Michel M.L., Davis H.L., Schleef M., Mancini M., Tiollais P., Whalen R.G. DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans. Proc Natl Acad Sci U S A. 92(12):1995;5307-5311
24. Habel A., Chanel C., Le Grand R., Martinon F., Couillin L., Moog C., et al. DNA vaccine protection against challenge with simian/human immunodeficiency virus 89.6 in rhesus macaques. Dev Biol. 104:2000;101-105
25. Firat H., Tourdot S., Ureta-Vidal A., Scardino A., Suhrbier A., Buseyne F., et al. Design of a polyepitope construct for the induction of HLA-A0201-restricted HIV 1-specific CTL responses using HLA-A*0201 transgenic, H-2 class I KO mice. Eur J Immunol. 31(10):2001;3064-3074
26. Karlsson G.B., Halloran M., Li J., Park I.W., Gomila R., Reimann K.A., et al. Characterization of molecularly cloned simian-human immunodeficiency viruses causing rapid CD4+ lymphocyte depletion in rhesus monkeys. J Virol. 71(6):1997;4218-4225
27. Reimann K.A., Li J.T., Veazey R., Halloran M., Park I.W., Karlsson G.B., et al. A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys. J Virol. 70(10):1996;6922-6928
28. Aubertin A.M., Le Grand R., Wang Y., Beyer C., Tao L., Neildez O., et al. Generation of CD8+ T-cell-generated suppressor factor and beta-chemokines by targeted iliac lymph node immunization in rhesus monkeys challenged with SHIV-89.6P by the rectal route. AIDS Res Hum Retrovir. 16(4):2000;381-392
29. Larsson M., Jin X., Ramratnam B., Ogg G.S., Engelmayer J., Demoitie M.A., et al. A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T-cells in HIV-1-positive individuals. AIDS. 13(7):1999;767-777
30. Guy B., Riviere Y., Dott K., Regnault A., Kieny M.P. Mutational analysis of the HIV nef protein. Virology. 176(2):1990;413-425
31. Lifson J.D., Rossio J.L., Piatak M. Jr., Parks T., Li L., Kiser R., et al. Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment. J Virol. 75(21):2001;10187-10199
32. Hofmann-Lehmann R., Swenerton R.K., Liska V., Leutenegger C.M., Lutz H., McClure H.M., et al. Sensitive and robust one-tube real-time reverse transcriptase-polymerase chain reaction to quantify SIV RNA load: comparison of one- versus two-enzyme systems. AIDS Res Hum Retrovir. 16(13):2000;1247-1257
33. Siegel S, Castellan NJ. Non parametric statistics for behavioral sciences. New York: McGraw-Hill; 1988.
34. Korber BTM, Walker BD, Brander C. HIV molecular immunology data base. Los Alamos National Laboratory; 1996.
35. Allen T.M., Sidney J., del Guercio M.F., Glickman R.L., Lensmeyer G.L., Wiebe D.A., et al. Characterisation of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus. J Immunol. 160(12):1998;6062-6071
36. Mortara L., Letourneur F., Gras-Masse H., Venet A., Guillet J.G., Bourgault-Villada I. Selection of virus variants and emergence of virus escape mutants after immunization with an epitope vaccine. J Virol. 72(2):1998;1403-1410
37. Evans D.T., Jing P., Allen T.M., O'Connor D.H., Horton H., Venham J.E., et al. Definition of five new simian immunodeficiency virus cytotoxic T-lymphocyte epitopes and their restricting major histocompatibility complex class I molecules: evidence for an influence on disease progression. J Virol. 74(16):2000;7400-7410
38. Voss G., Letvin N.L. Definition of human immunodeficiency virus type 1 gp 120 and gp41 cytotoxic T-lymphocyte epitopes and their restricting major histocompatibility complex class I alleles in simian-human immunodeficiency virus-infected Rhesus monkeys. J Virol. 70:1996;7335-7340
39. Muster T., Steindl F., Purtscher M., Trkola A., Klima A., Himmler G., et al. A conserved neutralising epitope on gp41 of human immunodeficiency virus type 1a. J Virol. 67:1993;6642-6647
40. Buseyne F., Le Gall S., Boccaccio C., Abastado J.P., Lifson J.D., Arthur L.O., et al. MHC-I-restricted presentation of HIV-1 virion antigens without viral replication. Nat Med. 7(3):2001;344-349
41. Shiver J.W., Fu T.M., Chen L., Casimiro D.R., Davies M.E., Evans R.K., et al. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature. 415(6869):2002;331-335
42. Egan M.A., Charini W.A., Kuroda M.J., Schmitz J.E., Racz P., Tenner-Racz K., et al. Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection. J Virol. 74(16):2000;7485-7495
43. Barouch D.H., Craiu A., Santra S., Egan M.A., Schmitz J.E., Kuroda M.J., et al. Elicitation of high-frequency cytotoxic T-lymphocyte responses against both dominant and subdominant simian-human immunodeficiency virus epitopes by DNA vaccination of rhesus monkeys. J Virol. 75(5):2001;2462-2467
44. Caulfield M.J., Wang S., Smith J.G., Tobery T.W., Liu X., Davies M.E., et al. Sustained peptide-specific gamma interferon T-cell response in rhesus macaques immunized with human immunodeficiency virus gag DNA vaccines. J Virol. 76(19):2002;10038-10043
45. Belyakov I.M., Hel Z., Kelsall B., Kuznetsov V.A., Ahlers J.D., Nacsa J., et al. Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques. Nat Med. 7(12):2001;1320-1326
46. Shedlock D.J., Shen H. Requirement for CD4 T-cell help in generating functional CD8 T-cell memory. Science. 300(5617):2003;337-339
47. Sun J.C., Bevan M.J. Defective CD8 T-cell memory following acute infection without CD4 T-cell help. Science. 300(5617):2003;339-342
48. Amara R.R., Villinger F., Staprans S.I., Altman J.D., Montefiori D.C., Kozyr N.L., et al. Different patterns of immune responses but similar control of a simian-human immunodeficiency virus 89.6P mucosal challenge by modified vaccinia virus Ankara (MVA) and DNA/MVA vaccines. J Virol. 76(15):2002;7625-7631
49. Casimiro D.R., Chen L., Fu T.M., Evans R.K., Caulfield M.J., Davies M.E., et al. Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene. J Virol. 77(11):2003;6305-6313
50. Robinson H.L., Montefiori D.C., Johnson R.P., Manson K.H., Kalish M.L., Lifson J.D., et al. Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations. Nat Med. 5(5):1999;526-534
51. Ling B., Veazey R.S., Luckay A., Penedo C., Xu K., Lifson J.D., et al. SIV(mac) pathogenesis in rhesus macaques of Chinese and Indian origin compared with primary HIV infections in humans. AIDS. 16(11):2002;1489-1496
52. Barouch D.H., Santra S., Schmitz J.E., Kuroda M.J., Fu T.M., Wagner W., et al. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science. 290(5491):2000;486-492